Charlotte Teunissen

Early predictive value of plasma biomarkers for amyloid positivity

Fluid biomarkers of immune function in Alzheimer’s disease

Blood biomarkers in AD: latest data, establishing SOPs, and new appropriate use guidelines

Impact of blood-based biomarkers on Alzheimer’s disease treatments

Challenges in the clinical implementation of Alzheimer’s disease biomarkers

The MIRIADE training program: development of dementia biomarkers

Using plasma biomarkers in the diagnosis of Alzheimer’s disease

Which plasma biomarkers hold the most promise in Alzheimer’s Disease?